BIVRX vs. QLEIX
BIVRX (Invenomic Fund) and QLEIX (AQR Long-Short Equity Fund) are both Long-Short funds. Over the past 5 years, BIVRX returned 10.20%/yr vs 22.70%/yr for QLEIX. At a 0.20 correlation, their price movements are largely independent. BIVRX charges 2.48%/yr vs 1.30%/yr for QLEIX.
Performance
BIVRX vs. QLEIX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BIVRX achieves a -6.17% return, which is significantly lower than QLEIX's -1.65% return.
BIVRX
- 1D
- 2.01%
- 1M
- 7.89%
- 6M
- -1.81%
- YTD
- -6.17%
- 1Y
- -2.74%
- 3Y*
- -2.20%
- 5Y*
- 10.20%
- 10Y*
- —
QLEIX
- 1D
- -0.14%
- 1M
- -0.81%
- 6M
- -0.72%
- YTD
- -1.65%
- 1Y
- 14.30%
- 3Y*
- 24.66%
- 5Y*
- 22.70%
- 10Y*
- 11.71%
BIVRX vs. QLEIX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BIVRX Invenomic Fund | -6.17% | 4.39% | -9.03% | 16.47% | 49.61% | 44.06% | 11.12% | 11.36% | 3.41% | 8.73% |
QLEIX AQR Long-Short Equity Fund | -1.65% | 34.43% | 30.50% | 23.95% | 19.18% | 31.10% | -13.92% | 1.19% | -16.33% | 8.52% |
Correlation
The correlation between BIVRX and QLEIX is -0.15, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.15 |
Correlation (3Y) Calculated over the trailing 3-year period | -0.18 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.11 |
Correlation (All Time) Calculated using the full available price history since Jun 23, 2017 | 0.20 |
The correlation between BIVRX and QLEIX shifts across timeframes, from -0.18 (3 years) to 0.20 (all time), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BIVRX vs. QLEIX — Risk / Return Rank
BIVRX
QLEIX
BIVRX vs. QLEIX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Invenomic Fund (BIVRX) and AQR Long-Short Equity Fund (QLEIX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BIVRX | QLEIX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.97 | ||
| Sortino ratioReturn per unit of downside risk | -2.67 | ||
| Omega ratioGain probability vs. loss probability | 1.00 | 1.34 | -0.33 |
| Calmar ratioReturn relative to maximum drawdown | -0.14 | 2.35 | -2.49 |
| Martin ratioReturn relative to average drawdown | -0.38 | 6.82 | -7.19 |
Loading charts...
Drawdowns
BIVRX vs. QLEIX - Drawdown Comparison
The maximum BIVRX drawdown since its inception was -27.37%, smaller than the maximum QLEIX drawdown of -38.11%. Use the drawdown chart below to compare losses from any high point for BIVRX and QLEIX.
Loading charts...
Drawdown Indicators
| BIVRX | QLEIX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -27.37% | -38.11% | +10.74% |
Max Drawdown (1Y)Largest decline over 1 year | -26.97% | -6.01% | -20.96% |
Max Drawdown (3Y)Largest decline over 3 years | -27.37% | -7.07% | -20.30% |
Max Drawdown (5Y)Largest decline over 5 years | -27.37% | -17.07% | -10.30% |
Max Drawdown (10Y)Largest decline over 10 years | — | -38.11% | — |
Current DrawdownCurrent decline from peak | -12.48% | -2.25% | -10.23% |
Average DrawdownAverage peak-to-trough decline | -6.20% | -7.69% | +1.49% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 9.87% | 2.07% | +7.80% |
Volatility
BIVRX vs. QLEIX - Volatility Comparison
Invenomic Fund (BIVRX) has a higher volatility of 17.23% compared to AQR Long-Short Equity Fund (QLEIX) at 3.29%. This indicates that BIVRX's price experiences larger fluctuations and is considered to be riskier than QLEIX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BIVRX | QLEIX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 17.23% | 3.29% | +13.94% |
Volatility (6M)Calculated over the trailing 6-month period | 26.03% | 6.23% | +19.80% |
Volatility (1Y)Calculated over the trailing 1-year period | 29.79% | 7.72% | +22.07% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 19.08% | 10.03% | +9.05% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.46% | 10.56% | +7.90% |
BIVRX vs. QLEIX - Expense Ratio Comparison
BIVRX has a 2.48% expense ratio, which is higher than QLEIX's 1.30% expense ratio.
Dividends
BIVRX vs. QLEIX - Dividend Comparison
BIVRX's dividend yield for the trailing twelve months is around 2.06%, more than QLEIX's 1.78% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BIVRX Invenomic Fund | 2.06% | 1.93% | 3.55% | 20.26% | 28.43% | 3.00% | 3.11% | 3.21% | 4.82% | 1.21% | 0.00% | 0.00% |
QLEIX AQR Long-Short Equity Fund | 1.78% | 1.75% | 7.12% | 20.88% | 14.15% | 0.00% | 1.57% | 0.00% | 6.03% | 9.11% | 3.01% | 4.98% |
Frequently Asked Questions
BIVRX and QLEIX have a correlation of -0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BIVRX has higher volatility (17.23%) compared to QLEIX (3.29%). In terms of maximum drawdown, BIVRX dropped -27.37% vs QLEIX's -38.11%.
QLEIX currently has the higher Sharpe Ratio (1.84 vs -0.12), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BIVRX and QLEIX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer